Literature DB >> 7247587

Moderate sodium restriction and various diuretics in the treatment of hypertension.

C V Ram, B N Garrett, N M Kaplan.   

Abstract

Changes in total body potassium level and blood pressure (BP) were determined in multiple studies on 12 hypertensive subjects ingesting a diet either moderately restricted or higher in sodium. On both diets, the following diuretics were randomly given for four-week intervals: chlorthalidone, hydrochlorothiazide, or furosemide. Total body exchangeable potassium level fell 225 mEq with lower sodium intake and 455 mEq with higher intake, combining all diuretics. Chlorthalidone caused more potassium wastage than the other diuretics. The average falls in mean BP were 13.9 mm Hg with the lower sodium diet and 9.1 with the higher sodium diet, combinging all diuretics. Combining both diets, chlorthalidone produced the greatest fall and furosemide produced the slightest. These data suggest that if a diuretic is used to treat hypertension, a diet moderately restricted in sodium and a single morning dose of a diuretic of intermediate duration of action offer the best balance of efficacy and safety for most patient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247587

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Drug Treatment of Hypertension: Controlling elevated blood pressure.

Authors:  D R Ryan
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 2.  Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.

Authors:  A Chockalingam; D Abbott; M Bass; R Battista; R Cameron; J de Champlain; C E Evans; J Laidlaw; B L Lee; L Leiter
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 3.  Is salt restriction relevant and feasible as adjunctive treatment of hypertension?

Authors:  M H Weinberger
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 4.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 5.  Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes.

Authors:  P Hamet; N Kalant; S A Ross; T W Wilson; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1988-12-01       Impact factor: 8.262

Review 6.  The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years.

Authors:  A G Dupont
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 7.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 8.  Electrolyte abnormalities and ventricular arrhythmias.

Authors:  P V Caralis; E Perez-Stable
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 9.  Can non-pharmacological interventions reduce doses of drugs needed for the treatment of hypertension? World Hypertension League.

Authors: 
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

10.  Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative.

Authors:  E M Mervaala; J Laakso; H Vapaatalo; H Karppanen
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.